ReviewF1000Research2020
Immunopathology of galectin-3: an increasingly promising target in COVID-19.
John L Caniglia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this paperpooled ittrialcites it
ReviewF1000Research2020
John L Caniglia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.